Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GlycoCheck is a medical technology company specializing in the non-invasive assessment of the endothelial glycocalyx, a protective layer lining the interior of all blood vessels. The company's proprietary system utilizes a high-speed digital camera and automated software to measure the MicroVascular Health Score (MVHS) by analyzing sublingual microcirculation. This technology allows clinicians and researchers to detect early-stage vascular damage before it manifests as clinical symptoms in conditions such as cardiovascular disease, diabetes, and sepsis. GlycoCheck's solutions are used globally in clinical research and are increasingly being integrated into preventative health and critical care monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GlycoCheck.